ANALYSIS OF THE OPINIONS OF WOMEN AND MEN OF DIFFERENT AGES ABOUT PSORIASIS
DOI:
https://doi.org/10.58407/bht.1.24.12Keywords:
psoriasis, opinion, respondents, women, menAbstract
Purpose: The study aimed to assess the knowledge of women and men of different ages about psoriasis, its symptoms and factors that trigger psoriasis symptoms.
Methodology. The study involved 100 respondents whose knowledge of psoriasis, its symptoms and factors that trigger psoriasis symptoms was assessed. The respondents included 28 men (28%) and 72 women (72%) aged between 17 and 65 years. The tool used in the study was a survey, which allowed data to be collected from respondents about their knowledge of psoriasis. The research tool used to conduct the study was an anonymous questionnaire. The study involved answering the survey questions independently, without the involvement of the researcher. There were 10 different types of questions in the survey. These included both personal details and questions about the respondents' subjective experiences.
Scientific novelty. When asked if they had ever heard of the condition, 91 respondents said they had. For both women and men in all age groups, the percentage of respondents who had heard of psoriasis was around 90%. Respondents under 30 knew the correct answer to the question about the age at which symptoms first appear (70-80%). The question about the contagiousness of the disease also gave satisfactory results: the majority of respondents (up to 89.5%) answered that psoriasis is not contagious. The question "What disease is psoriasis?", which asked about the aetiology of the disease (chronic, autoimmune and genetic), again showed that, with the exception of respondents aged 31 to 40 who gave only one correct answer, the rest of the respondents (26.1-57.9%) chose the correct answer. Unfortunately, knowledge of the symptoms of psoriasis is very low, with only 27.5% of all respondents marking the symptoms of psoriasis. The majority (45.1%) chose the description of atopic dermatitis. The question about the symptoms of psoriasis of the nail also showed a very low level of awareness among respondents, with only 20.2% giving the correct answer. When it comes to the factors that trigger the symptoms of the condition in question, the most common answers were stress (30%), infection (28.9%) and skin damage (18.9%), which is correct. Men and women of all ages most often agreed that psoriasis can be a contraindication to cosmetic procedures, but depending on the type of procedure; this gives satisfactory results and proves that people with psoriasis can, according to the respondents, use cosmetic services despite skin changes. The question about periods of remission also showed that respondents had a satisfactory knowledge of this subject, as the correct answer – that there are periods of remission in this disease - was given by the largest number of respondents in each study group (between 50 and 100%).
Downloads
References
Amanat, M., Salehi, M., & Rezaei, N. (2018). Neurological and psychiatric disorders in psoriasis. Reviews in the neurosciences, 29(7), 805–813. https://doi.org/10.1515/revneuro-2017-0108
Armstrong, A. W., & Read, C. (2020). Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA, 323(19), 1945–1960. https://doi.org/10.1001/jama.2020.4006
Armstrong, A., Jarvis, S., Boehncke, W. H., Rajagopalan, M., Fernández-Peñas, P., Romiti, R., Bewley, A., Vaid, B., Huneault, L., Fox, T., Sodha, M., & Warren, R. B. (2018). Patient perceptions of clear/almost clear skin in moderate-to-severe plaque psoriasis: results of the clear about psoriasis worldwide survey. Journal of the European Academy of Dermatology and Venereology: JEADV, 32(12), 2200–2207. https://doi.org/10.1111/jdv.15065
Bangemann, K., Schulz, W., Wohlleben, J., Weyergraf, A., Snitjer, I., Werfel, T., Schmid-Ott, G., & Böhm, D. (2014). Depression and anxiety disorders among psoriasis patients: protective and exacerbating factors. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 65(12), 1056–1061. https://doi.org/10.1007/s00105-014-3513-9. (in German).
Böhm, D., Stock Gissendanner, S., Bangemann, K., Snitjer, I., Werfel, T., Weyergraf, A., Schulz, W., Jäger, B., & Schmid-Ott, G. (2013). Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. Journal of the European Academy of Dermatology and Venereology: JEADV, 27(2), 220–226. https://doi.org/10.1111/j.1468-3083.2012.04451.x
Budu-Aggrey, A., Brumpton, B., Tyrrell, J., Watkins, S., Modalsli, E. H., Celis-Morales, C., Ferguson, L. D., Vie, G.Å., Palmer, T., Fritsche, L. G., Løset, M., Nielsen, J. B., Zhou, W., Tsoi, L. C., Wood, A. R., Jones, S.E., Beaumont, R., Saunes, M., Romundstad, P. R., Siebert, S., … Paternoster, L. (2019). Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study. PLoS medicine, 16(1), e1002739. https://doi.org/10.1371/journal.pmed.1002739
Chen, M., Jiang, Q., & Zhang, L. (2021). The prevalence of bipolar disorder in autoimmune disease: a systematic review and meta-analysis. Annals of palliative medicine, 10(1), 350–361. https://doi.org/ 10.21037/apm-20-2293
Chodorowska, G., Bryczek, M., Dąbrowska-Członka, M., & Bartosińska, J. (2006). To what extent are psoriasis patients interested in their disease? – preliminary examination. Advances in Dermatology and Allergology, XXIII(4), 186-191. (in Polish)
Coles, R. B., & Ryan, T. J. (1975). The psoriasis sufferer in the community. The British journal of dermatology, 93(1), 111–113. https://doi.org/10.1111/j.1365-2133.1975.tb06486.x
Dand, N., Mahil, S. K., Capon, F., Smith, C. H., Simpson, M. A., & Barker, J. N. (2020). Psoriasis and Genetics. Acta dermato-venereologica, 100(3), adv00030. https://doi.org/10.2340/00015555-3384
De Jager, M. E. A., De Jong, E. M. G. J., Evers, A. W. M., Van De Kerkhof, P. C. M., & Seyger, M. M. B. (2011). The burden of childhood psoriasis. Pediatric dermatology, 28(6), 736–737. https://doi.org/10.1111/ j.1525-1470.2011.01489.x
Dimitrov, D., & Szepietowski, J. C. (2017a). Stigmatization in dermatology with a special focus on psoriatic patients. Postepy higieny i medycyny doswiadczalnej (Online), 71(0), 1115–1122. https://doi.org/10.5604/01.3001.0010.6879
Dimitrov, D., & Szepietowski, J. C. (2017b). Instruments to assess stigmatization in dermatology. Postepy higieny i medycyny doswiadczalnej (Online), 71(0), 901–905. https://doi.org/10.5604/ 01.3001.0010.5607
Dimitrov, D., Matusiak, Ł., Evers, A., Jafferany, M., & Szepietowski, J. (2019). Arabic language skin-related stigmatization instruments: Translation and validation process. Advances in clinical and experimental medicine: official organ Wroclaw Medical University, 28(6), 825–832. https://doi.org/ 10.17219/acem/102617
Fortune, D. G., Richards, H. L., Kirby, B., McElhone, K., Markham, T., Rogers, S., Main, C. J., & Griffiths, C. E. (2003). Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Archives of dermatology, 139(6), 752–756. https://doi.org/10.1001/archderm. 139.6.752
Ginsburg, I. H., & Link, B. G. (1989). Feelings of stigmatization in patients with psoriasis. Journal of the American Academy of Dermatology, 20(1), 53–63. https://doi.org/10.1016/s0190-9622(89)70007-4
Gupta, M. A., & Gupta, A. K. (1995). Age and gender differences in the impact of psoriasis on quality of life. International journal of dermatology, 34(10), 700–703. https://doi.org/10.1111/j.1365-4362. 1995.tb04656.x
Haassengier, V., Zborowska, A., & Rozensztrauch, A. (2015). Analysis of the level of knowledge of the Polish society about autoimmune diseases on the example of psoriasis vulgaris - preliminary report. In I. Uchmanowicz, J. Rosińczuk, & B. Jankowskiej-Polańskiej (Eds.), Scientific research in nursing and midwifery, (pp 1-10). T. 2. Wydawnictwo Continuo. (in Polish)
Hawro, M., Maurer, M., Weller, K., Maleszka, R., Zalewska-Janowska, A., Kaszuba, A., Gerlicz-Kowalczuk, Z., & Hawro, T. (2017). Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis. Journal of the American Academy of Dermatology, 76(4), 648–654.e2. https://doi.org/10.1016/j.jaad.2016.10.040
Hayes, J., & Koo, J. (2010). Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatologic therapy, 23(2), 174–180. https://doi.org/10.1111/j.1529-8019.2010.01312.x
Hrehorów, E., Salomon, J., Matusiak, L., Reich, A., & Szepietowski, J.C. (2012). Patients with psoriasis feel stigmatized. Acta dermato-venereologica, 92(1), 67–72. https://doi.org/10.2340/00015555-1193
Innamorati, M., Quinto, R.M., Lester, D., Iani, L., Graceffa, D., & Bonifati, C. (2018). Cognitive impairment in patients with psoriasis: A matched case-control study. Journal of psychosomatic research, 105, 99–105. https://doi.org/10.1016/j.jpsychores.2017.12.011
Jabłońska, S., & Chorzelski, T. (2001). Skin diseases. Wydawnictwo PZWL. (in Polish)
Jankowiak, B., Kowalewska, B., Fiodaravich Khvorik, D., Krajewska-Kułak, E., & Niczyporuk, W. (2016). The level of stigmatization and depression of patients with psoriasis. Iranian journal of public health, 45(5), 690–692.
Jankowiak, B., Kowalewska, B., Krajewska-Kułak, E., & Khvorik, D.F. (2020). Stigmatization and quality of life in patients with psoriasis. Dermatology and therapy, 10(2), 285–296. https://doi.org/ 10.1007/s13555-020-00363-1
Jankowiak, B., Kowalewska, B., Krajewska-Kułak, E., Kowalczuk, K., & Khvorik, D.F. (2021). The sense of stigmatization in patients with plaque psoriasis. Dermatology (Basel, Switzerland), 237(4), 611–617. https://doi.org/10.1159/000510654
Kaszuba, A., Szepietowski, J., & Adamski, Z. (2016). Dermatologia geriatryczna. Wydawnictwo Czelej.
Kowalewska, B., Cybulski, M., Jankowiak, B., & Krajewska-Kułak, E. (2020). Acceptance of illness, satisfaction with life, sense of stigmatization, and quality of life among people with psoriasis: a cross-sectional study. Dermatology and therapy, 10(3), 413–430. https://doi.org/10.1007/s13555-020-00368-w
Lanna, C., Galluzzi, C., Zangrilli, A., Bavetta, M., Bianchi, L., & Campione, E. (2022). Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma. The Journal of dermatological treatment, 33(1), 531–534. https://doi.org/10.1080/ 09546634.2020.1770175
Łakuta, P., Marcinkiewicz, K., Bergler-Czop, B., Brzezińska-Wcisło, L., & Słomian, A. (2018). Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients. Postepy dermatologii i alergologii, 35(1), 60–66. https://doi.org/10.5114/pdia.2016.62287
Masson, W., Lobo, M., & Molinero, G. (2020). Psoriasis and cardiovascular risk: a comprehensive review. Advances in therapy, 37(5), 2017–2033. https://doi.org/10.1007/s12325-020-01346-6
Neneman, A., & Adamski, Z. (2009). Aspekty kliniczne i epidemiologiczne zaburzeń ogólno-ustrojowych u chorych na łuszczycę. Forum Medycyny Rodzinnej, 3(6), 449.
Parisi, R., Iskandar, I. Y. K., Kontopantelis, E., Augustin, M., Griffiths, C. E. M., Ashcroft, D. M., & Global Psoriasis Atlas (2020). National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ (Clinical research ed.), 369, m1590. https://doi.org/10.1136/ bmj.m1590
Pearl, R. L., Wan, M. T., Takeshita, J., & Gelfand, J. M. (2019). Stigmatizing attitudes toward persons with psoriasis among laypersons and medical students. Journal of the American Academy of Dermatology, 80(6), 1556–1563. https://doi.org/10.1016/j.jaad.2018.08.014
Perrott, S. B., Murray, A. H., Lowe, J., & Mathieson, C. M. (2000). The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiology & behavior, 70(5), 567–571. https://doi.org/10.1016/s0031-9384(00)00290-0.
Raharja, A., Mahil, S. K., & Barker, J. N. (2021). Psoriasis: a brief overview. Clinical medicine (London, England), 21(3), 170–173. https://doi.org/10.7861/clinmed.2021-0257
Rigon, R. B., de Freitas, A. C. P., Bicas, J. L., Cogo-Müller, K., Kurebayashi, A. K., Magalhães, R. F., & Leonardi, G. R. (2021). Skin microbiota as a therapeutic target for psoriasis treatment: Trends and perspectives. Journal of cosmetic dermatology, 20(4), 1066–1072. https://doi.org/10.1111/jocd. 13752
Romańska-Gocka, K. (2009). Farmakoterapia łuszczycy. Farmacja Polska, 65(9), 647-654.
Rubino, I. A., Sonnino, A., Pezzarossa, B., Ciani, N., & Bassi, R. (1995). Personality disorders and psychiatric symptoms in psoriasis. Psychological reports, 77(2), 547–553. https://doi.org/10.2466/ pr0.1995.77.2.547
Rycroft, R. J. G., Robertson, S. J., & Wakelin, S. H. (2014). Dermatologia. Wydawnictwo PZWL. (in Polish)
Schön, M. P., & Erpenbeck, L. (2018). The Interleukin-23/Interleukin-17 axis links adaptive and innate immunity in psoriasis. Frontiers in immunology, 9, 1323. https://doi.org/10.3389/fimmu. 2018.01323.
Sommer, R., Mrowietz, U., Radtke, M. A., Schäfer, I., von Kiedrowski, R., Strömer, K., Enk, A., Maul, J.T., Reich, K., Zander, N., & Augustin, M. (2018). What is psoriasis? – Perception and assessment of psoriasis among the German population. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG, 16(6), 703–710. https://doi.org/10.1111/ ddg.13539
Sommer, R., Topp, J., Mrowietz, U., Zander, N., & Augustin, M. (2020). Perception and determinants of stigmatization of people with psoriasis in the German population. Journal of the European Academy of Dermatology and Venereology: JEADV, 34(12), 2846–2855. https://doi.org/10.1111/jdv.16436
Susskind, W., & McGuire, R. J. (1959). The emotional factor in psoriasis. Scottish medical journal, 4, 503–507. https://doi.org/10.1177/003693305900401007
van Beugen, S., van Middendorp, H., Ferwerda, M., Smit, J.V., Zeeuwen-Franssen, M.E., Kroft, E.B., de Jong, E.M., Donders, A.R., van de Kerkhof, P.C., & Evers, A.W. (2017). Predictors of perceived stigmatization in patients with psoriasis. The British journal of dermatology, 176(3), 687–694. https://doi.org/10.1111/bjd.14875
Vardy, D., Besser, A., Amir, M., Gesthalter, B., Biton, A., & Buskila, D. (2002). Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. The British journal of dermatology, 147(4), 736–742. https://doi.org/10.1046/j.1365-2133.2002.04899.x
Veale, D. J., & Fearon, U. (2018). The pathogenesis of psoriatic arthritis. Lancet (London, England), 391(10136), 2273–2284. https://doi.org/10.1016/S0140-6736(18)30830-4.
Wolska, H. (2009). Psoriasis. Wydawnictwo PZWL. (in Polish)
Zhang, H., Yang, Z., Tang, K., Sun, Q., & Jin, H. (2021). Stigmatization in patients with psoriasis: A Mini Review. Frontiers in immunology, 12, 715839. https://doi.org/10.3389/fimmu.2021.715839
Zięciak, T., Rzepa, T., Król, J., & Żaba, R. (2017). Stigmatization feelings and depression symptoms in psoriasis patients. Poczucie stygmatyzacji a objawy depresyjne u osób chorych na łuszczycę. Psychiatria polska, 51(6), 1153–1163. https://doi.org/10.12740/PP/68848
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Наталія Яжджевська, Галина Ткаченко, Наталія Кургалюк
This work is licensed under a Creative Commons Attribution 4.0 International License.
